This draft Commission Implementing Decision repeals the postponement of the expiry date of the approval of bromoacetic acid for use in biocidal products of product type (PT) 4. On 22 December 2023, an application was submitted in accordance with Article 13(1) of Regulation (EU) No 528/2012 for the renewal of the approval of bromoacetic acid for use in biocidal products of product-type 4. On 8 April 2026, the applicant informed the evaulating Competent Authority that it had withdrawn their application for the renewal of approval of bromoacetic acid for product-type 4. Consequently, a draft Decision is being prepared to not renew the approval of bromoacetic acid for PT 4. Further to that Decision, it is necessary to repeal the postponement of the expiry date of the approval of bromoacetic acid for PT 4. The present draft Decision therefore intends to repeal Decision (EU) 2025/360.